{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T06:22:13Z","timestamp":1777184533040,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000106","name":"Saskatchewan Health Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000106","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.preghy.2026.101423","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T12:55:06Z","timestamp":1770123306000},"page":"101423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Low molecular weight heparin (LMWH) therapy guided by low placental growth factor (PlGF) in a diabetes-prevalent population: preliminary retrospective cohort"],"prefix":"10.1016","volume":"43","author":[{"given":"Ernesto A.","family":"Figueiro-Filho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genevieve M.","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alysa","family":"Poulin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrielle P.","family":"Souza Lira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adewumi","family":"Adanlawo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro Henrique","family":"Goncalves Guedes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Paula","family":"Mendes-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua D.","family":"Buse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.preghy.2026.101423_b0005","doi-asserted-by":"crossref","unstructured":"R.J. Levine, C. Lam, C. Qian, K.F. Yu, S.E. Maynard, B.P. Sachs, B.M. Sibai, F.H. Epstein, R. Romero, R. Thadhani, S.A. Karumanchi, C.S. Group, Soluble endoglin and other circulating antiangiogenic factors in preeclampsia, N Engl J Med 355(10) (2006) 992\u20131005.","DOI":"10.1056\/NEJMoa055352"},{"key":"10.1016\/j.preghy.2026.101423_b0010","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2147\/IJWH.S368454","article-title":"Perspectives on the use of placental growth factor (PlGF) in the prediction and diagnosis of pre-eclampsia: recent insights and future steps","volume":"15","author":"Creswell","year":"2023","journal-title":"Int. J. Womens Health"},{"issue":"4","key":"10.1016\/j.preghy.2026.101423_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogoh.2025.102925","article-title":"Predictive performance of sFlt-1, PlGF and the sFlt-1\/PlGF ratio for preeclampsia: a systematic review and meta-analysis","volume":"54","author":"Zhang","year":"2025","journal-title":"J. Gynecol. Obstet. Hum. Reprod."},{"issue":"11","key":"10.1016\/j.preghy.2026.101423_b0020","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.44454","article-title":"Midpregnancy placental growth factor screening and early preterm birth","volume":"7","author":"Gladstone","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.preghy.2026.101423_b0025","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.931943","article-title":"First-trimester sequential screening for preeclampsia using angiogenic factors: study protocol for a prospective, multicenter, real clinical setting study","volume":"9","author":"Trilla","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.preghy.2026.101423_b0030","doi-asserted-by":"crossref","unstructured":"A. Aviram, E. Mei-Dan, G. Cassir, E. Figueiro-Filho, J. Liauw, V. Jain, E. Bujold, N. Melamed, S.C.O. Committee, F. Audibert, I. Boucoiran, E. Cohen, J. Coolen, M.D. Dionne, E.F. Filho, M. Gomes, S. Hobson, K. Lim, C. Nash, K. Niles, G. Smith, S. Walji, G. Wilcock, K. Wou, S.G.M.O. Committee, M. Basso, J. Cook, D. Francoeur, B. Guthrie, K. Harris, S. Healey, V. Jain, B. Jim, A. Kotaska, A. Metcalfe, N.L. McLeod, A. Murji, J. Papillon-Smith, V. Poliquin, F. Potestio, A. Smith, R.D. Wilson, Technical Update No. 462: Abnormal maternal serum markers and adverse pregnancy outcomes, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC (2025) 103060.","DOI":"10.1016\/j.jogc.2025.103060"},{"key":"10.1016\/j.preghy.2026.101423_b0035","doi-asserted-by":"crossref","unstructured":"M.L. Cote, Y. Giguere, J.C. Forest, F. Audibert, J.A. Johnson, N. Okun, P. Guerby, L. Ghesquiere, E. Bujold, First-Trimester PLGF and PAPP-A and the Risk of Placenta-Mediated Complications: PREDICTION Prospective Study, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC (2024) 102732.","DOI":"10.1016\/j.jogc.2024.102732"},{"issue":"22","key":"10.1016\/j.preghy.2026.101423_b0040","doi-asserted-by":"crossref","first-page":"6759","DOI":"10.3390\/jcm11226759","article-title":"Contribution of second trimester sonographic placental morphology to uterine artery doppler in the prediction of placenta-mediated pregnancy complications","volume":"11","author":"Ashwal","year":"2022","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.preghy.2026.101423_b0045","article-title":"The role of placental growth factor in the prediction of carbohydrate and thyroid disorders during pregnancy","volume":"58","author":"Yanachkova","year":"2022","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"10.1016\/j.preghy.2026.101423_b0050","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1038\/s41598-021-81785-5","article-title":"Placental and maternal sFlt1\/PlGF expression in gestational diabetes mellitus","volume":"11","author":"Nuzzo","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.preghy.2026.101423_b0055","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1017\/S2040174417000988","article-title":"The hefty fetal phenotype hypothesis revisited: high birth weight, type 2 diabetes and gestational diabetes in a Saskatchewan cohort of first Nations and non-first Nations women","volume":"10","author":"Dyck","year":"2019","journal-title":"J. Dev. Orig. Health Dis."},{"key":"10.1016\/j.preghy.2026.101423_b0060","unstructured":"I.M. Bistervels, A. Buchmuller, H.M.G. Wiegers, F. Ni Ainle, B. Tardy, J. Donnelly, P. Verhamme, A.F. Jacobsen, A.T. Hansen, M.A. Rodger, M.T. DeSancho, R.G. Shmakov, N. van Es, M.H. Prins, C. Chauleur, S. Middeldorp, c. Highlow Block writing, I. Highlow, Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial, Lancet (London, England) 400(10365) (2022) 1777\u20131787."},{"issue":"4","key":"10.1016\/j.preghy.2026.101423_b0065","doi-asserted-by":"crossref","first-page":"H1008","DOI":"10.1152\/ajpheart.00109.2020","article-title":"Low molecular weight heparin promotes transcription and release of placental growth factor from endothelial cells, American journal of physiology","volume":"318","author":"McLaughlin","year":"2020","journal-title":"Heart Circulatory Physiol."},{"key":"10.1016\/j.preghy.2026.101423_b0070","doi-asserted-by":"crossref","unstructured":"K. McLaughlin, S.R. Hobson, A.R. Chandran, S. Agrawal, R.C. Windrim, W.T. Parks, A.W. Bowman, U. Sovio, G.C. Smith, J.C. Kingdom, Circulating maternal placental growth factor responses to low-molecular-weight heparin in pregnant patients at risk of placental dysfunction, Am J Obstet Gynecol 226(2S) (2022) S1145\u2013S1156.e1.","DOI":"10.1016\/j.ajog.2021.08.027"},{"issue":"1","key":"10.1016\/j.preghy.2026.101423_b0075","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12884-023-06218-9","article-title":"Low-molecular-weight heparin for the prevention of preeclampsia in high-risk pregnancies without thrombophilia: a systematic review and meta-analysis","volume":"24","author":"Chen","year":"2024","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.preghy.2026.101423_b0080","doi-asserted-by":"crossref","unstructured":"M. Cruz-Lemini, J.C. Vazquez, J. Ullmo, E. Llurba, Low-molecular-weight heparin for prevention of preeclampsia and other placenta-mediated complications: a systematic review and meta-analysis, Am J Obstet Gynecol 226(2S) (2022) S1126\u2013S1144 e17.","DOI":"10.1016\/j.ajog.2020.11.006"},{"issue":"8","key":"10.1016\/j.preghy.2026.101423_b0085","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1111\/jog.15319","article-title":"Low molecular weight heparin and pregnancy outcomes in women with inherited thrombophilia: a systematic review and meta-analysis","volume":"48","author":"Chen","year":"2022","journal-title":"J. Obstet. Gynaecol. Res."},{"issue":"12","key":"10.1016\/j.preghy.2026.101423_bib211","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogc.2025.103120","article-title":"Implementation of Placental Growth Factor in a Tertiary Western Canadian Centre: Association with Ultrasound Findings and Perinatal Outcomes","volume":"47","author":"Figueiro-Filho","year":"2025","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.preghy.2026.101423_bib212","article-title":"Placental Growth Factor (PlGF) Between 12 + 0\u201320 + 6 Weeks' Gestation and Perinatal Outcomes in a High Prevalent Diabetes Population: A Retrospective Cohort Study","author":"Dietrich","year":"2025","journal-title":"BJOG"},{"issue":"3","key":"10.1016\/j.preghy.2026.101423_b0090","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/uog.15884","article-title":"Consensus definition of fetal growth restriction: a Delphi procedure","volume":"48","author":"Gordijn","year":"2016","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2026.101423_b0095","doi-asserted-by":"crossref","unstructured":"L.A. Magee, G.N. Smith, C. Bloch, A.M. Cote, V. Jain, K. Nerenberg, P. von Dadelszen, M. Helewa, E. Rey, Guideline No. 426: Hypertensive Disorders of Pregnancy: Diagnosis, Prediction, Prevention, and Management, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 44(5) (2022) 547\u2013571 e1.","DOI":"10.1016\/j.jogc.2022.03.002"},{"issue":"7","key":"10.1016\/j.preghy.2026.101423_b0100","doi-asserted-by":"crossref","first-page":"698","DOI":"10.5858\/arpa.2015-0225-CC","article-title":"Sampling and definitions of placental lesions: amsterdam placental workshop group consensus statement","volume":"140","author":"Khong","year":"2016","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"2","key":"10.1016\/j.preghy.2026.101423_b0105","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.path.2022.02.001","article-title":"Life after amsterdam: placental pathology consensus recommendations and beyond","volume":"15","author":"Slack","year":"2022","journal-title":"Surg. Pathol. Clin."},{"key":"10.1016\/j.preghy.2026.101423_b0110","doi-asserted-by":"crossref","unstructured":"R.L. Leon, K. Sharma, I.N. Mir, C.L. Herrera, S.L. Brown, C.Y. Spong, L.F. Chalak, Placental vascular malperfusion lesions in fetal congenital heart disease, Am J Obstet Gynecol 227(4) (2022) 620 e1\u2013620 e8.","DOI":"10.1016\/j.ajog.2022.05.038"},{"issue":"2","key":"10.1016\/j.preghy.2026.101423_b0115","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ajog.2022.03.042","article-title":"Maternal vascular malperfusion of the placental bed is a common pathophysiological process that underlies fetal death, early fetal growth restriction, and related hypertensive disorders","volume":"227","author":"Carbillon","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2026.101423_b0120","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.placenta.2020.11.012","article-title":"Placental mitochondrial function in response to gestational exposures","volume":"104","author":"Lu","year":"2021","journal-title":"Placenta"},{"key":"10.1016\/j.preghy.2026.101423_b0125","doi-asserted-by":"crossref","unstructured":"K.M. Groom, L.M. McCowan, L.K. Mackay, A.C. Lee, J.M. Said, S.C. Kane, S.P. Walker, T.E. van Mens, N.J. Hannan, S. Tong, L.W. Chamley, P.R. Stone, C. McLintock, P. Enoxaparin for Prevention of, G. Intrauterine Growth Restriction Trial Investigator, Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a history: a randomized trial, Am J Obstet Gynecol 216(3) (2017) 296 e1\u2013296 e14.","DOI":"10.1016\/j.ajog.2017.01.014"},{"issue":"7","key":"10.1016\/j.preghy.2026.101423_b0130","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1590\/S0102-86502014000700001","article-title":"Effects of enoxaparin and unfractionated heparin in prophylactic and therapeutic doses on the fertility of female Wistar rats","volume":"29","author":"Figueir\u00f3-Filho","year":"2014","journal-title":"Acta Cir. Bras."},{"issue":"1","key":"10.1016\/j.preghy.2026.101423_b0135","first-page":"40","article-title":"Serum markers of inherited thrombophilia and antiphospholipid antibodies in pregnant women with previous history of severe pre-eclampsia","volume":"34","author":"Figueiro-Filho","year":"2012","journal-title":"Rev. Bras. Ginecol. Obstet."},{"key":"10.1016\/j.preghy.2026.101423_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.placenta.2016.03.010","article-title":"Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction","volume":"42","author":"Benton","year":"2016","journal-title":"Placenta"},{"issue":"1","key":"10.1016\/j.preghy.2026.101423_b0145","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/HYPERTENSIONAHA.116.08298","article-title":"Low molecular weight heparin improves endothelial function in pregnant women at high risk of preeclampsia","volume":"69","author":"McLaughlin","year":"2017","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.preghy.2026.101423_b0150","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14113838","article-title":"The role of placental mitochondrial dysfunction in adverse perinatal outcomes: a systematic review","volume":"14","author":"Voros","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.preghy.2026.101423_b0155","article-title":"Multiple analytical perspectives of mitochondrial genes in the context of preeclampsia: potential diagnostic markers","volume":"16","author":"Li","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.preghy.2026.101423_b0160","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2024.1344951","article-title":"Mitochondrial quality control alterations and placenta-related disorders","volume":"15","author":"Wu","year":"2024","journal-title":"Front. Physiol."},{"issue":"4","key":"10.1016\/j.preghy.2026.101423_b0165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24044177","article-title":"Placental mitochondrial function and dysfunction in preeclampsia","volume":"24","author":"Jahan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.preghy.2026.101423_b0170","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11906-022-01184-7","article-title":"Mitochondrial dysfunction in the pathogenesis of preeclampsia","volume":"24","author":"Hu","year":"2022","journal-title":"Curr. Hypertens. Rep."},{"issue":"3","key":"10.1016\/j.preghy.2026.101423_b0175","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/humupd\/dmaa053","article-title":"Adaptations of the human placenta to hypoxia: opportunities for interventions in fetal growth restriction","volume":"27","author":"Colson","year":"2021","journal-title":"Hum. Reprod. Update"},{"issue":"7","key":"10.1016\/j.preghy.2026.101423_b0180","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.preghy.2026.101423_b0185","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1007\/s11010-021-04215-0","article-title":"Bioenergetics adaptations and redox homeostasis in pregnancy and related disorders","volume":"476","author":"Sanchez-Aranguren","year":"2021","journal-title":"Mol. Cell. Biochem."},{"issue":"7","key":"10.1016\/j.preghy.2026.101423_b0190","article-title":"MZe786 rescues cardiac mitochondrial activity in high sflt-1 and low HO-1 environment","volume":"9","author":"Sanchez-Aranguren","year":"2020","journal-title":"Antioxidants (basel)"},{"issue":"11","key":"10.1016\/j.preghy.2026.101423_b0195","doi-asserted-by":"crossref","DOI":"10.3390\/cells10112817","article-title":"Progesterone induced blocking factor reduces hypertension and placental mitochondrial dysfunction in response to sflt-1 during pregnancy","volume":"10","author":"Deer","year":"2021","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.preghy.2026.101423_b0200","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.preghy.2016.06.004","article-title":"Trophoblast mitochondrial function is impaired in preeclampsia and correlates negatively with the expression of soluble fms-like tyrosine kinase 1","volume":"6","author":"Zsengeller","year":"2016","journal-title":"Pregnancy Hypertens"},{"issue":"3","key":"10.1016\/j.preghy.2026.101423_b0205","first-page":"162","article-title":"Effects of heparin and dalteparin on oxidative stress during hemodialysis in patients with end-stage renal disease","volume":"3","author":"Nassiri","year":"2009","journal-title":"Iran. J. Kidney Dis."},{"issue":"3","key":"10.1016\/j.preghy.2026.101423_b0210","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2337\/diacare.25.3.487","article-title":"A comparison of rates, risk factors, and outcomes of gestational diabetes between aboriginal and non-aboriginal women in the Saskatoon health district","volume":"25","author":"Dyck","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.preghy.2026.101423_bib213","article-title":"Placental Growth Factor (PlGF) and Fetal Macrosomia: A Retrospective Cohort Study in a Western Canadian Tertiary Centre","volume":"103229","author":"Figueiro-Filho","year":"2026","journal-title":"J. Obstet. Gynaecol. Can."}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778926000103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778926000103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T11:37:05Z","timestamp":1776166625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778926000103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":45,"alternative-id":["S2210778926000103"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2026.101423","relation":{},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low molecular weight heparin (LMWH) therapy guided by low placental growth factor (PlGF) in a diabetes-prevalent population: preliminary retrospective cohort","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2026.101423","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of International Society for the Study of Hypertension in Pregnancy.","name":"copyright","label":"Copyright"}],"article-number":"101423"}}